Delivery Order SPE2DB25D3201-SPE2DB25FNTDJ
Award Date
5/13/25
Potential Completion Date
5/14/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,553.88, is for the delivery of 4,568,075,876 units of the drug Cyclophosphamide 500 mg vials. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is the prime...
This federal contract award, valued at $8,730.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,557,853,913 units of the drug Cyclophosphamide 2 GM Vials. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award, valued at $9,483.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,721,442 units of Cyclophosphamide 2 GM vials, a critical pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of March 28, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,134.58, is for the delivery of 4,564,661,962 units of the drug Cyclophosphamide 2 GM Vials. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a period of performance ending on May 21, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Cyclophosphamide 2 GM vials. The $14,682.20 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a performance period through November 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award is a delivery order, valued at $14,682.20, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,567,254,079 vials of the drug Cyclophosphamide, at 2 grams per vial. The contract has a firm-fixed price pricing type and a period of performance running through February 13, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
This federal contract award, valued at $1,463.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,261,768 vials of the pharmaceutical drug cyclophosphamide 1 GM. The contract is a firm fixed price delivery order with an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This award...
This federal contract award is for the delivery of Cyclophosphamide 2 GM vials to the Defense Logistics Agency (DLA). The $9,120.41 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 6, 2024, with a performance period ending on December 9, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclophosphamide 2 GM/10 ML VL 10ML, a medical product, with a ceiling value of $3,139.38 and a period of performance through May 7, 2025. The contract is a firm fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is for the delivery of Cyclophosphamide 2 GM vials to support healthcare programs administered by the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with a ceiling value of $10,761.60 and a completion date of September 1, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and open...